专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5359097A Process for preparation of glycidyl ether 失效
标题翻译：缩水甘油醚的制备方法
公开(公告)号：US5359097A
公开(公告)日：1994-10-25
申请号：US571543
申请日：1990-08-22
申请人： Kiyoshi Kawamura , Tomio Ota
发明人： Kiyoshi Kawamura , Tomio Ota
IPC分类号： C07D301/28 , C07D303/22 , C07D405/12 , C07D407/12 , C07D417/12 , C07D311/04
CPC分类号： C07D303/22 , C07D407/12
摘要： A process is provided for preparation of a glycidyl ether represented by the general formula ##STR1## wherein A represents an aryl group optionally having a substituent or a heteroaryl group optionally having a substituent, and the carbon atom marked with * is an asymmetric carbon,which comprises reacting an aryl alcohol represented by the general formulaA--OH (I)wherein A is as defined above,with an epihalohydrin in the presence of a quaternary ammonium salt; and, if necessary, further treating the reaction product with a base. According to the present process, it is possible to prepare by simple procedures and in a high optical purity glycidyl ethers of the above formula (II) useful as an intermediate for preparation of medicines, particularly medicines having .beta.-adrenoreceptor blocking action or the like.
摘要翻译： PCT No.PCT / JP89 / 01293 Sec。 371 1990年7月18日第 102（e）日期1990年7月18日PCT提交1989年12月25日PCT公布。出版物WO90 / 07506 日本1990年7月12日提供了一种制备由任选具有取代基的通式或由任选具有取代基的杂芳基表示的缩水甘油醚的方法，标有*的碳原子是不对称碳，其包括使由季铵盐存在下的表卤代醇，由通式A-OH（I）表示的芳基醇，其中A如上所定义; 并且如果需要，用碱进一步处理反应产物。根据本方法，可以通过简单的方法和上述式（II）的高光学纯度的缩水甘油醚制备，其可用作制备药物的中间体，特别是具有β-肾上腺素受体阻断作用的药物等。

2. 发明申请

US20140336377A1 ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS 有权
标题翻译： ARYLAMIDE衍生物作为TTX-S阻挡剂
公开(公告)号：US20140336377A1
公开(公告)日：2014-11-13
申请号：US13879673
申请日：2011-10-18
申请人： Tatsuya Yamagishi , Kiyoshi Kawamura , Yoshimasa Arano , Mikio Morita
发明人： Tatsuya Yamagishi , Kiyoshi Kawamura , Yoshimasa Arano , Mikio Morita
IPC分类号： C07D213/64 , C07D213/75 , C07D239/42 , C07D471/04 , C07D413/12 , C07D413/14 , C07D401/12 , C07D401/14
CPC分类号： C07D213/64 , A61K31/44 , A61K31/4427 , A61K31/444 , A61K31/506 , C07D213/75 , C07D213/81 , C07D239/42 , C07D401/12 , C07D401/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04
摘要： The present invention relates to arylamide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.
摘要翻译：本发明涉及具有电压门控钠通道作为TTX-S通道的阻断活性的芳基酰胺衍生物，其可用于治疗或预防涉及电压门控钠通道的疾病和疾病。本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病中的用途。

3. 发明申请

US20120094964A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS 审中-公开
标题翻译：磺酰胆碱衍生物作为TRPM8拮抗剂
公开(公告)号：US20120094964A1
公开(公告)日：2012-04-19
申请号：US13318212
申请日：2010-05-06
申请人： Tadashi Inoue , Masashi Ohmi , Kiyoshi Kawamura , Kazuo Ando , Yuji Shishido
发明人： Tadashi Inoue , Masashi Ohmi , Kiyoshi Kawamura , Kazuo Ando , Yuji Shishido
IPC分类号： A61K31/635 , A61K31/18 , A61K31/495 , A61K31/4453 , A61K31/5377 , A61K31/444 , A61K31/4439 , C07D213/76 , C07C311/21 , C07D295/192 , C07D413/12 , C07D401/12 , A61P29/00 , A61P13/00 , A61P19/08 , A61P25/00 , A61P25/06 , A61P9/10 , A61P1/00 , A61P25/22 , A61P25/24 , A61P11/06 , A61P11/00 , A61P9/12 , A61P13/10 , A61P35/00 , A61P13/02 , A61K31/44
CPC分类号： C07C311/21 , A61K31/18 , A61K31/196 , A61K31/44 , A61K31/443 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4453 , A61K31/4709 , A61K31/495 , A61K31/5375 , A61K31/5377 , A61K45/06 , C07D213/42 , C07D213/75 , C07D295/13 , C07D295/185 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/12 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , A61K2300/00
摘要： The present invention relates to sulfamoyl benzoic acid derivatives of formula (I) or a pharmaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the TRPM8 receptor.
摘要翻译：本发明涉及式（I）的氨磺酰苯甲酸衍生物或其药学上可接受的盐，其制备方法，含有它们的药物组合物及其用于治疗通过TRPM8受体介导的各种病症的用途。

4. 发明授权

US07964727B2 Quinolonecarboxylic acid compounds having 5-HT4 receptor agonistic activity 失效
标题翻译：具有5-HT 4受体激动活性的喹诺酮羧酸化合物
公开(公告)号：US07964727B2
公开(公告)日：2011-06-21
申请号：US10595948
申请日：2004-11-10
申请人： Tomoki Kato , Kiyoshi Kawamura , Mikio Morita , Chikara Uchida
发明人： Tomoki Kato , Kiyoshi Kawamura , Mikio Morita , Chikara Uchida
IPC分类号： C07D221/02 , C07D215/00 , C07D413/00 , A01N43/40 , A01N43/42 , A61K31/435 , A61K31/44
CPC分类号： C04B35/632 , C07D401/12 , C07D401/14 , C07D405/14
摘要： This invention provides a compound of the formula (I): wherein Het represents a heterocyclic group having one nitrogen atom, to which B binds directly, and from 4 to 7 carbon atoms, and said heterocyclic group being unsubstituted or substituted by 1 to 4 substituents independently selected from the group consisting of substituents α1; A represents an alkylene group having from 1 to 4 carbon atoms; B represents a covalent bond or an alkylene group having from 1 to 5 carbon atoms; R1 represents an isopropyl group, a n-propyl group or a cyclopentyl group; R2 represents a methyl group, a fluorine atom or a chlorine atom; R3 independently represents (i) an oxo group, a hydroxy group, an amino group, an alkylamino group or a carboxyl group; (ii) a cycloalkyl group having from 3 to 8 carbon atoms, and said cycloalkyl group being substituted by 1 to 5 substituents, or (iii) a heterocyclic group having from 3 to 8 atoms, and said heterocyclic group being unsubstituted or substituted by 1 to 5 substituents, and n is 1, 2 or 3, or a pharmaceutically acceptable salts thereof. These compounds have 5-HT4 receptor agonistic activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome or the like in mammalian, especially humans.
摘要翻译：本发明提供式（I）化合物：其中Het表示具有一个氮原子的杂环基团，B直接与该碳原子结合，并且具有4至7个碳原子，所述杂环基团未被取代或被1至4个取代基取代独立地选自取代基α1; A表示具有1至4个碳原子的亚烷基; B表示共价键或具有1至5个碳原子的亚烷基; R1表示异丙基，正丙基或环戊基; R2表示甲基，氟原子或氯原子; R3独立地表示（i）氧代基，羟基，氨基，烷基氨基或羧基; （ii）具有3至8个碳原子的环烷基，所述环烷基被1至5个取代基取代，或（iii）具有3至8个原子的杂环基，所述杂环基未被取代或被1 至5个取代基，n为1,2或3，或其药学上可接受的盐。这些化合物具有5-HT 4受体激动活性，因此可用于治疗哺乳动物特别是人类的胃食管反流病，非溃疡性消化不良，功能性消化不良，肠易激综合征等。

5. 发明授权

US07645830B2 Polymer, crosslinked polymer, composition for solid polymer electrolyte, solid polymer electrolyte, and adhesive composition 有权
标题翻译：聚合物，交联聚合物，固体聚合物电解质的组合物，固体聚合物电解质和粘合剂组合物
公开(公告)号：US07645830B2
公开(公告)日：2010-01-12
申请号：US11795783
申请日：2006-01-18
申请人： Takeshi Niitani , Masato Amaike , Mikiya Shimada , Kiyoshi Kawamura
发明人： Takeshi Niitani , Masato Amaike , Mikiya Shimada , Kiyoshi Kawamura
IPC分类号： C08F118/02 , C08L31/02 , C09J167/06
CPC分类号： C08F293/005 , C08F290/06 , C08F293/00 , C08F297/02 , C08F297/026 , C08G18/6229 , C08L25/04 , C08L27/16 , C08L29/02 , C08L53/00 , C08L71/02 , C08L75/04 , C08L2205/05 , C08L2666/02 , C09J153/00 , H01M10/052 , H01M10/0565 , H01M2300/0082 , C08L2666/04
摘要： A polymer including a block chain A which is formed from a random copolymer containing a repeating unit (I) represented by the formula (I) wherein R1 to R3 each independently represents hydrogen or C1-10 hydrocarbon and R1 and R3 may bond to form a ring; R4a and R4b each independently represents hydrogen or methyl; R5 represents hydrogen, hydrocarbon, acyl, or silyl; and m represents any integer of 1 to 100 and when m is 2 or more and each R4a may be the same or different from one another and each R4b may be the same or different from one another; and a repeating unit (II) represented by the formula (II) wherein R6 and R8 each independently represents hydrogen or C1-10 hydrocarbon and R6 and R8 may bond to form a ring; R7 represents hydrogen, C1-10 hydrocarbon, hydroxyl, hydrocarbonoxy, carboxyl, acid anhydride, amino, ester, or an organic group having at least one functional group selected from the group consisting of hydroxyl, carboxyl, epoxy, acid anhydride, and amino; and R9 represents an organic group having at least one functional group selected from the group consisting of hydroxyl, carboxyl, epoxy, acid anhydride, and amino; and a block chain B having a repeating unit (III) represented by the formula (III) wherein R10 to R12 each independently represents hydrogen or C1-10 hydrocarbon and R13 represents aryl or heteroaryl; and wherein an arrangement order thereof is B, A, B.
摘要翻译：一种包含嵌段链A的聚合物，其由含有式（I）表示的重复单元（I）的无规共聚物形成，其中R 1至R 3各自独立地表示氢或C 1-10烃，并且R 1和R 3可以键合形成环; R4a和R4b各自独立地表示氢或甲基; R5表示氢，烃，酰基或甲硅烷基; m表示1〜100的整数，m为2以上时，各R 4a可以相同也可以不同，各R 4a可以相同也可以不同。和由式（II）表示的重复单元（II），其中R6和R8各自独立地表示氢或C1-10烃，R6和R8可以键合形成环; R7表示氢，C1-10烃，羟基，烃氧基，羧基，酸酐，氨基，酯或具有至少一个选自羟基，羧基，环氧基，酸酐和氨基的官能团的有机基团; 并且R 9表示具有至少一个选自羟基，羧基，环氧基，酸酐和氨基的官能团的有机基团; 和具有由式（III）表示的重复单元（III）的嵌段链B，其中R10至R12各自独立地表示氢或C1-10烃，R13表示芳基或杂芳基; 其布置顺序为B，A，B。

6. 发明授权

US07589109B2 Oxyindole derivatives 失效
标题翻译：氧吲哚衍生物
公开(公告)号：US07589109B2
公开(公告)日：2009-09-15
申请号：US11360095
申请日：2006-02-22
申请人： Chikara Uchida , Hiroki Sone , Kiyoshi Kawamura
发明人： Chikara Uchida , Hiroki Sone , Kiyoshi Kawamura
IPC分类号： A61K31/454 , C07D403/14
CPC分类号： C07D401/12 , C07D401/14 , C07D405/14
摘要： This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, R1, R2, R3, R4 and R5 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by 5-HT4 agonistic activity such as, but not limited to, as gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome (IBS), constipation, dyspepsia, esophagitis, gastroesophageal disease, nausea, central nervous system disease, Alzheimer's disease, cognitive disorder, emesis, migraine, neurological disease, pain, cardiovascular disorders, cardiac failure, heart arrhythmia, diabetes or apnea syndrome.
摘要翻译：本发明涉及式（I）化合物或其药学上可接受的盐，其中：A，R 1，R 2，R 3，R 4和R 5各自如本文所述或其药学上可接受的盐，以及含有这些化合物的组合物和使用这些化合物治疗由5-HT4激动活性介导的病症，例如但不限于胃食道反流病，胃肠道疾病，胃动力障碍，非溃疡性消化不良，功能性消化不良，肠易激综合征（IBS）），便秘，消化不良，食道炎，胃食管疾病，恶心，中枢神经系统疾病，阿尔茨海默病，认知障碍，呕吐，偏头痛，神经系统疾病，疼痛，心血管疾病，心力衰竭，心律失常，糖尿病或呼吸暂停综合征。

7. 发明申请

US20080293767A1 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity 失效
标题翻译：具有5-Ht4受体激动活性的1-异丙基-2-氧代-1,2-二氢吡啶-3-甲酰胺衍生物
公开(公告)号：US20080293767A1
公开(公告)日：2008-11-27
申请号：US10597480
申请日：2005-01-18
申请人： Tomoki Kato , Kiyoshi Kawamura , Chikara Uchida
发明人： Tomoki Kato , Kiyoshi Kawamura , Chikara Uchida
IPC分类号： A61K31/4545 , A61P3/00 , A61P25/00 , A61P1/00 , A61P9/00 , C07D405/14 , C07D401/12
CPC分类号： C07D401/12 , C07D405/14
摘要： This invention provides a compound of formula (I): wherein R1 represents an alkyl group having from 1 to 4 carbon atoms or a halogen atom, R2 represents an alkyl group having from 1 to 4 carbon atoms, R3 represents a hydrogen atom or a hydroxy group, and A represents an oxygen atom or a group of the formula —C(R4)(R5)— (in which R4 represents a hydrogen atom or an alkyl group having from 1 to 4 carbon atoms and R5 represents a hydroxy group or an alkoxy group having from 1 to 4 carbon atoms) or a pharmaceutically acceptable salts thereof. These compounds have 5-HT4 receptor agonistic activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome or the like in mammalian, especially humans.
摘要翻译：本发明提供式（I）化合物：其中R 1表示具有1至4个碳原子的烷基或卤原子，R 2表示具有1至4个碳原子的烷基，R 3表示氢原子或羟基基团，A表示氧原子或式-C（R4）（R5） - （其中R4表示氢原子或具有1至4个碳原子的烷基，R5表示羟基或式具有1至4个碳原子的烷氧基）或其药学上可接受的盐。这些化合物具有5-HT 4受体激动活性，因此可用于治疗哺乳动物特别是人类的胃食管反流病，非溃疡性消化不良，功能性消化不良，肠易激综合征等。

8. 发明申请

US20080269211A1 Indazole Derivatives 失效
标题翻译：吲唑衍生物
公开(公告)号：US20080269211A1
公开(公告)日：2008-10-30
申请号：US11995179
申请日：2006-07-14
申请人： Asako Ishibashi , Tomoki Kato , Kiyoshi Kawamura , Sachiko Mihara , Mikio Morita
发明人： Asako Ishibashi , Tomoki Kato , Kiyoshi Kawamura , Sachiko Mihara , Mikio Morita
IPC分类号： A61K31/416 , A61P1/00 , A61P25/00 , A61P9/00 , C07D401/12 , C07D405/14 , A61K31/5377 , C07D403/12 , C07D413/14 , C07D401/14 , A61K31/454
CPC分类号： C07D401/12 , C07D403/12 , C07D405/14
摘要： This invention relates to compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein: R1, R2, R3, A and m are each as described herein and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by 5-HT4 agonistic activity such as, but not limited to, gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome (IBS), constipation, dyspepsia, esophagitis, gastroesophageral disease, nausea, central nervous system disease, Alzheimer's disease, cognitive disorder, emesis, migraine, neurological disease, pain, cardiovascular disorders, cardiac failure, heart arrhythmia, diabetes and apnea syndrome.
摘要翻译：本发明涉及式（I）化合物或其药学上可接受的盐，其中：R 1，R 2，R 3， A和m各自如本文所述，含有这些化合物的组合物和这些化合物在治疗由5-HT 4激动剂活性介导的病症中的用途，例如但不限于胃食管反流疾病，胃肠道疾病，胃动力障碍，非溃疡性消化不良，功能性消化不良，肠易激综合征（IBS），便秘，消化不良，食管炎，胃食管疾病，恶心，中枢神经系统疾病，阿尔茨海默氏病，认知障碍，呕吐，偏头痛，神经疾病，疼痛，心血管疾病，心力衰竭，心律失常，糖尿病和呼吸暂停综合征。

9. 发明授权

US06380470B1 Training system for music performance, keyboard musical instrument equipped therewith and training keyboard 有权
标题翻译：用于音乐表演的训练系统，配备的键盘乐器和训练键盘
公开(公告)号：US06380470B1
公开(公告)日：2002-04-30
申请号：US09547279
申请日：2000-04-11
申请人： Yuji Fujiwara , Kiyoshi Kawamura , Taro Kawabata
发明人： Yuji Fujiwara , Kiyoshi Kawamura , Taro Kawabata
IPC分类号： G09B1500
CPC分类号： G10H1/0008 , G10H2220/061
摘要： A keyboard musical instrument has keys equal to a multiple of five assigned to the fingers of a trainee, an electric tutor and an electronic sound generating system, and the electric tutor gives the trainee guide in practicing the fingering along a passage, wherein the electronic sound generating system generates the tones when the trainee satisfies predetermined conditions for the training so as to correctly guide him in the practice.
摘要翻译：键盘乐器具有等于分配给受训者，电导师和电子声音产生系统的手指的五分之一的键，并且电导师给导师指导沿着通道练习指法，其中电子声音当学员满足训练的预定条件时，生成系统产生音调，以便在实践中正确引导他。

10. 发明授权

US06281422B1 Music performance assisting system for teaching sequential use of fingers, method used therein and information storage medium for computer program representative of the method 失效
标题翻译：用于教导手指顺序使用的音乐表演辅助系统，其中使用的方法和代表该方法的计算机程序的信息存储介质
公开(公告)号：US06281422B1
公开(公告)日：2001-08-28
申请号：US09520577
申请日：2000-03-08
申请人： Kiyoshi Kawamura
发明人： Kiyoshi Kawamura
IPC分类号： G09B1504
CPC分类号： G10H1/0016
摘要： A music performance assisting system analyzes a set of music data codes representative of a series of notes and rests forming a tune, and selectively assigns the notes to the five fingers of each hand of a player, wherein the music performance assisting system temporarily assigns notes of each of plural note groups to the fingers in accordance with rules of a fingering for obtaining candidates of a finger pattern, and, thereafter, evaluates the candidates on the basis of rules of a desirable fingering so as to determine the optimum use of fingers so as to decrease the data base and speed up the data processing.
摘要翻译：音乐表演辅助系统分析代表一系列音符的一组音乐数据代码，并且休息形成乐曲，并且将音符选择性地分配给玩家的每只手的五根手指，其中音乐表演辅助系统暂时分配根据用于获取手指图案的候选者的指法的规则，将手指的多个音符组中的每一个根据期望的指法的规则评估候选，以便确定手指的最佳使用，以便减少数据库并加快数据处理速度。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式